Cardiovascular disease risk factors and cognitive impairmentDavid T Nash
Upstate Medical University, Syracuse Preventive Cardiology, Syracuse, New York, USA
Am J Cardiol 97:1262-5. 2006
..Antioxidants, fatty acids, and micronutrients may have a role, and diets rich in fruits and vegetables and other dietary approaches may improve the outlook for patients considered at risk for cognitive impairment...
- The clinical implications and management of concomitant hypertension and dyslipidemia
David T Nash
State University of New York at Syracuse, Upstate Medical Center, USA
Postgrad Med 119:37-45. 2006
..The authors also discuss important new findings documenting the need for, and benefits of, a more integrated approach to treating this dangerous duo...
- Rationale for combination therapy in hypertension management: focus on angiotensin receptor blockers and thiazide diuretics
David T Nash
State University of New York Upstate Medical University, Syracuse Preventive Cardiology Center, Syracuse, NY 13202, USA
South Med J 100:386-92. 2007
..Complementary combinations of antihypertensive agents provide an efficient and effective approach to hypertension management...
Relationship of C-reactive protein, metabolic syndrome and diabetes mellitus: potential role of statinsDavid T Nash
Syracuse Preventive Cardiology, State University of New York Health Sciences Center, Syracuse, NY 13202, USA
J Natl Med Assoc 97:1600-7. 2005
..In the future, assessment of CRP levels may contribute importantly to clinical decision-making in reducing cardiovascular risk...
- The case for medical treatment in chronic stable coronary artery disease
David T Nash
Syracuse Preventive Cardiology, and Department of Medicine, State University of New York at Syracuse, Health Sciences Center, 600 E. Genesee Street, Presidential Plaza Suite 204, Syracuse, NY 13202, USA
Arch Intern Med 165:2587-9, discussion 2593-4. 2005
- Use of vascular ultrasound in clinical trials to evaluate new cardiovascular therapies
David T Nash
Upstate Medical University, Syracuse Preventive Cardiology, Syracuse, NY, USA
J Natl Med Assoc 100:222-9. 2008
..Both IVUS and CIMT are being widely deployed in trials of new and existing CV therapies to assess their impact on slowing the progression of atherosclerosis, and their use in this regard is the subject of this review...
- Achieving BP goals with valsartan and HCTZ alone and in combination: pooled analysis of two randomized, double-blind, placebo-controlled studies
David T Nash
Upstate Medical University College of Medicine, Syracuse, NY 13202, USA
Curr Med Res Opin 24:2617-26. 2008
..Most patients with hypertension will require combination therapy to achieve blood pressure (BP) goals, especially the elderly, obese, or those with stage 2 hypertension...
Ranolazine for chronic stable anginaDavid T Nash
Syracuse Preventive Cardiology, Syracuse, NY 13202, USA
Lancet 372:1335-41. 2008
..Ranolazine seems to be a safe addition to current traditional drugs for chronic stable angina, especially in aggressive multidrug regimens...
- Cardiovascular risk factors and dementia
Howard Fillit
Institute for the Study of Aging and the Alzheimer s Drug Discovery Foundation, New York, New York 10019, USA
Am J Geriatr Pharmacother 6:100-18. 2008
..Evidence is accumulating to suggest that cardiovascular disease (CVD) risk factors may be instrumental in the development of dementia...
- Systolic hypertension
David T Nash
SUNY Upstate Medical University, Syracuse Preventive Cardiology Center, Syracuse, NY, USA
Geriatrics 61:22-8. 2006
..In addition to blood pressure-lowering efficacy, the combination of these two classes of metabolically neutral agents may offer benefit in terms of tolerability and cognitive function...
- Cardiovascular risk beyond LDL-C levels. Other lipids are performers in cholesterol story
David T Nash
State University of New York Upstate Medical University College of Medicine, Syracuse, USA
Postgrad Med 116:11-5. 2004
..He emphasizes that although studies have expanded the understanding of this disease, the knowledge needs to be put to use more consistently in clinical practice in order to provide optimal patient care...
- Statins. Evidence of effectiveness in older patients
David T Nash
Upstate Medical University, State University of New York, Syracuse, USA
Geriatrics 58:35-6, 39-42. 2003
..Despite these benefits, older adults are currently undertreated for this highly treatable cardiovascular risk factor...
- Nuts as part of a healthy cardiovascular diet
Stephen D Nash
Department of Medicine, SUNY Upstate Medical University, 6141 University Hospital, 750 E Adams Street, Syracuse, NY 13210, USA
Curr Atheroscler Rep 10:529-35. 2008
..Incorporating nuts into the diets of more people may lead to a variety of cardiovascular benefits...
- Translating current knowledge into dementia prevention
Gustavo C Roman
Alzheimer and Dementia Center, Methodist Neurological Institute Weill Cornell Medical College, The Methodist Hospital, Houston, TX SUNY Upstate Medical University and Syracuse Preventive Cardiology, Syracuse The Alzheimer s Drug Discovery Foundation The Mount Sinai School of Medicine, New York, NY
Alzheimer Dis Assoc Disord 26:295-9. 2012
....
- Keeping an eye on cardiovascular risk. A practical, case-study approach to assessment in office practice
David T Nash
American Heart Association, State University of New York Health Science Center, Syracuse College of Medicine, NY, USA
Postgrad Med 111:107-10, 113-4, 119-20. 2002
....
- Insulin resistance, ADMA levels, and cardiovascular disease
David T Nash
JAMA 287:1451-2. 2002
- A statin for a patient with hyperlipidemia and hepatitis C?
David T Nash
State University of New York, Health Science Center, Syracuse College of Medicine, USA
Postgrad Med 115:86. 2004
- Outcomes of medical vs invasive therapy for elderly patients with angina
David T Nash
JAMA 289:2794; author reply 2794. 2003
- Need for a moratorium on percutaneous transluminal coronary angioplasty in stable coronary artery disease
David T Nash
Am J Cardiol 89:567-70. 2002
- Invasive and medical therapy for coronary artery disease
David T Nash
Lancet 359:354-5. 2002
